-
MLI papers recommend changes to Canada’s pharma patent regime
Canada’s complacency about intellectual property (IP) is threatening its relative position in the global pharmaceutical industry, and changes are needed in IP protection to re-establish Canada as a global competitor. This is the thrust of two papers published by the Macdonald-Laurier Institute.